methamphetamine
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
7882
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
March 28, 2026
A History of Methamphetamine Use Disorder in People with HIV Is Associated with Altered Functional Response to Risky Choice.
(PubMed, Viruses)
- "A longer estimated duration of HIV infection was associated with greater ACC activation to risky choices for PWH regardless of METH use history. These findings suggest that PWH and a history of METH use disorder may exhibit compensatory activation of regions associated with decision-making in the context of rewards and that the effects of HIV and past METH use might not be additive."
Journal • Human Immunodeficiency Virus • Infectious Disease
March 28, 2026
Circuit and molecular mechanisms underlying incubation of methamphetamine craving in the prelimbic cortex.
(PubMed, Neuron)
- "Selective KCNC2 knockdown in SST or PV INs significantly suppressed drug seeking during early or prolonged withdrawal, respectively. These findings uncover the distinct contributions of PL IN subtypes to the incubation of craving and identify KCNC2 as a potential phase-specific therapeutic target in MUD."
Journal
January 10, 2026
Pathology of Vaccine-Preventable Diseases
(USCAP 2026)
- "Case 2 58-year-old man with history of methamphetamine use...Comfort with histologic diagnosis and assistance from microbiology colleagues is key. Postmortem diagnostic techniques include Gram stain Tissue culture PCR: tissue and CSF Evening Specialty Presentation (PDF): Click to View"
Atrial Fibrillation • Cardiovascular • Chronic Obstructive Pulmonary Disease • CNS Disorders • Epilepsy • Hematological Disorders • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Obstructive Sleep Apnea • Otorhinolaryngology • Pneumococcal Infections • Pneumonia • Pulmonary Disease • Pulmonary Embolism • Respiratory Diseases • Septic Shock • Sleep Apnea • Sleep Disorder • Systemic Lupus Erythematosus • Thrombosis
March 27, 2026
CCK2R regulates METH-induced CPP acquisition within VTA-BLA-BNST circuit in male mice.
(PubMed, Transl Psychiatry)
- "Methamphetamine (METH) addiction is a severe public health issue driven by maladaptive neuroplasticity in reward circuits...Electrophysiological and Golgi staining analyses confirmed CCK2R's critical role in regulating neuronal excitability and structural plasticity. Our findings demonstrate that CCK2R in the VTADA→BLAGlu → BNST circuit is essential for METH CPP acquisition, highlighting its potential as a therapeutic target for addiction."
Journal • Preclinical • CNS Disorders • Psychiatry • CCKBR
March 27, 2026
The Association Between Drug Craving and Suicidal Thoughts and Behavior in Chinese Male Methamphetamine Inpatients: The Mediating Effect of Depressive Symptoms.
(PubMed, Subst Use Misuse)
- "Depressive symptoms serve as a mediator in the relationship between drug craving and STBs in MAUD inpatients. These findings highlight the necessity of incorporating depressive symptoms screening and intervention into addiction treatment which may be related to a lower prevalence of suicide risk."
Journal • CNS Disorders • Depression • Psychiatry • Suicidal Ideation
March 27, 2026
Clarifying Selected Citations and Interpretations in 'Underage deaths associated with substance-related harm in Taiwan: A national 10-year study'.
(PubMed, Addiction)
- No abstract available
Journal
March 27, 2026
Cardiovascular Conditions and Symptoms in Deaths Attributed to Acute Stimulant Toxicity.
(PubMed, Circ Popul Health Outcomes)
- "The underlying cause of deaths attributed to acute stimulant (methamphetamine or cocaine) toxicity is poorly understood, although cardiovascular events are believed to contribute. Premortem cardiovascular conditions and symptoms were common among stimulant decedents and were more prevalent among deaths attributed to stimulants without opioids compared with those involving fentanyl. In addition to opioid overdose prevention efforts, people who use stimulants might benefit from aggressive prevention and treatment of cardiovascular disease."
Journal • Addiction (Opioid and Alcohol) • Cardiovascular • CNS Disorders • Coronary Artery Disease • Hypertension
March 27, 2026
Effects of nonpharmacological manipulations and repeated xanomeline treatment on methamphetamine-vs-food choice in Sprague Dawley and Long Evans rats.
(PubMed, Drug Alcohol Depend)
- "These results demonstrate that methamphetamine-vs-food choice was sensitive to parametric manipulations in rats and that xanomeline may warrant further consideration as a MUD pharmacotherapy."
Journal • Preclinical
March 26, 2026
A decade of change: trends in drug and alcohol use in Iran (2010-2019).
(PubMed, BMC Public Health)
- "The increasing prevalence of drugs and alcohol is alarming. Understanding these trends is essential for shaping public health policies and interventions."
Journal
March 26, 2026
From substance-induced psychosis to schizophrenia: Predictors of treatment response and transition to chronic psychotic illness-A systematic review.
(PubMed, Schizophr Res)
- "Treatment response in SIPDs is determined by multiple interacting factors. Moderate-certainty predictors (temporal onset, negative symptoms, premorbid functioning) provide the strongest basis for clinical decision-making, while lower-certainty findings require validation before widespread implementation."
Journal • Review • CNS Disorders • Psychiatry • Schizophrenia
March 25, 2026
Direct Methamphetamine Sensing in Flowing Wastewater via a 3D-Printed Flow-Through Cell.
(PubMed, J Xenobiot)
- "To our knowledge, this is the first demonstration of direct electrochemical sensing of MET in flowing wastewater using a 3D-printed flow-through platform. The simple, disposable design provides an actionable foundation for portable, near-real-time sewer surveillance and motivates antifouling/auto-cleaning strategies for long-term deployment."
Journal
March 25, 2026
Paradoxical role of the mesocorticolimbic Netrin1-DCC pathway in social competition and vulnerability to methamphetamine abuse during adolescence.
(PubMed, Mol Psychiatry)
- "Following dopamine fiber immunostaining, these outcomes were attributed to ectopic mesolimbic dopamine fibers, which enhanced risk-taking behavior in winners that had DCC knockout. Collectively, our work elucidates a molecular mechanism through which social competition influences adolescent brain development and behavior, particularly in relation to drug susceptibility."
Journal • Colorectal Cancer • Oncology • Solid Tumor • DCC • NTN1
March 25, 2026
Differences in anxiety, depression, and heart rate variability between patients with methamphetamine use disorder and heroin use disorder patients on methadone maintenance treatment.
(PubMed, BMC Psychiatry)
- No abstract available
Journal • CNS Disorders • Depression • Mood Disorders • Psychiatry
March 25, 2026
Stimulant-induced Psychosis: A Comparative Systematic Review and Meta-analysis of Psychotic Outcomes from Therapeutic and Nontherapeutic Use of Stimulants.
(PubMed, J Addict Med)
- "Stimulant-induced psychosis occurs in both therapeutic and nontherapeutic contexts but at vastly different prevalence rates. While prescribed stimulants pose a low but clinically relevant risk, particularly in individuals with psychiatric vulnerability, nontherapeutic use carries a substantial burden of psychosis with significant public health implications. These findings underscore the need for careful monitoring in clinical practice, risk profiling, and targeted harm-reduction strategies in nonmedical use settings."
Journal • Retrospective data • ADHD (Impulsive Aggression) • Attention Deficit Hyperactivity Disorder • CNS Disorders • Psychiatry
March 25, 2026
The effect of rTMS combined with physical exercise on people with methamphetamine use disorders: An acute experimental study.
(PubMed, J Psychiatr Res)
- "A single session of moderate-intensity physical exercise demonstrates acute benefits for both psychological and physiological withdrawal recovery in people with MUD. More importantly, it is essential to combine rTMS (particularly 10 Hz) with physical exercise, as this integrated approach can strengthen the sustainability of benefits and serve as an effective supplementary method to promote both physical and psychological recovery in this population."
Journal • CNS Disorders • Depression • Mood Disorders • Psychiatry
March 25, 2026
The reach, effectiveness, implementation, and maintenance of a New York City harm reduction program enrolling priority populations who use meth, 2017-2022.
(PubMed, Drug Alcohol Depend)
- "At reassessment, less than half reported recent methamphetamine use. Seroconversions occurred mostly among MSM of color, suggesting that greater engagement and support are needed for priority populations. Findings align with prior research showing frequent HIV seroconversion and a high need for non-medical services among MSM using methamphetamine."
Journal • Human Immunodeficiency Virus • Infectious Disease
March 25, 2026
Dynamic shifts in crystal methamphetamine and heroin price and purity in metropolitan Melbourne and rural Victoria, Australia, 2009-2020.
(PubMed, Int J Drug Policy)
- "Overall declines in both crystal methamphetamine and heroin purity-adjusted prices in Victoria suggests that, by 2019, people who purchased these drugs received more drug for a given purchase than in previous years. These changes closely match trends seen in some key harms such as opioid overdose."
Journal • Addiction (Opioid and Alcohol) • CNS Disorders • Epilepsy
March 25, 2026
Drug positivity, co-detection patterns, and demographic predictors in patients seeking substance use disorder treatment, United States, 2023.
(PubMed, Addict Behav)
- "This study highlights variations in substance presence and co-detection across 14 drug categories in SUD treatment patients, underscoring the need for tailored prevention and treatment strategies."
Journal
March 24, 2026
Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
(clinicaltrials.gov)
- P=N/A | N=20 | Completed | Sponsor: Queen's Medical Center | Recruiting ➔ Completed | Trial completion date: Sep 2025 ➔ Dec 2025 | Trial primary completion date: Sep 2025 ➔ Dec 2025
Trial completion • Trial completion date • Trial primary completion date
March 20, 2026
Neurostructural alterations, trait impulsivity, and genetic architecture in individuals with methamphetamine dependence: a multimodal imaging-genetics study.
(PubMed, Transl Psychiatry)
- "These findings suggest the thalamus as a critical structural substrate that links impulse control with METH-related neurotoxicity, emphasizing the role of cytoskeletal dynamics and ciliary function. Genetic variants that influence thalamic vulnerability may serve as promising biomarkers for risk stratification and the development of personalized interventions in MUD."
Journal
March 20, 2026
What Is Known about Substance Use in Hawai'i: A Scoping Review.
(PubMed, Hawaii J Health Soc Welf)
- "The granularity of geographical data was found to be at island-level and the 3 most common substances reported were alcohol, marijuana, and methamphetamine. Most documents used national datasets for reporting substance use in Hawai'i. The findings identified gaps in the literature that can be filled by future research such as focusing on the rise of substance use among older adults, disaggregating data on Pacific Islander populations in Hawai'i, reporting substance use data in geographical areas smaller than island-level, increasing the collection of data on groups that have a high risk for health problems or are underserved by health services, and intensifying collection of data about fentanyl use in Hawai'i."
Journal • Substance Abuse
February 25, 2026
The Complex Relationship between ADHD, Substance Use Disorders, and Prescription Stimulants
(PAS 2026)
- "When used appropriately, prescription stimulants in adolescents and adults with ADHD do not increase the risk for SUD. Virtual care of ADHD appears safe in terms of subsequent stimulant and other SUDs. Learning Objectives: Participants will be able to describe the association between adolescent prescription stimulant misuse and later risk for cocaine and methamphetamine use in young adulthood."
ADHD (Impulsive Aggression) • Attention Deficit Hyperactivity Disorder • CNS Disorders • Psychiatry
March 17, 2026
Susac Syndrome in an ICU Patient With History of Methamphetamine Use
(SCCM 2026)
- "Rituximab was chosen over cyclophosphamide to minimize further immunosuppression in the setting of persistent respiratory infection. Furthermore, the case underscores the challenges of initiating immunomodulators for Susac syndrome patients in the ICU setting. Early collaboration with a multidisciplinary team, especially with specialties such as neurology and ophthalmology, is essential for maximizing patient outcomes."
Clinical • CNS Disorders • Infectious Disease • Ophthalmology • Otorhinolaryngology • Rare Diseases • Respiratory Diseases • Septic Shock
March 17, 2026
Fatal Toxic Exposure: Fentanyl, "Dust-Off," or Both?
(SCCM 2026)
- "Given overlapping features with opioid toxicity, especially in polysubstance users, this case underscores the importance of considering inhalants in the differential diagnosis of drug-related cardiac arrest.Description: A 32-year-old female with IVDU and polysubstance abuse (methamphetamine, opioids, inhalants) was found unresponsive after unknown downtime. EMS identified PEA arrest; CPR, two rounds of epinephrine, and 6 mg naloxone were given, achieving ROSC...Early recognition is critical due to rapid onset and risk of irreversible hypoxic injury. Greater awareness is needed, as these agents are widely available, frequently abused, and often overlooked."
Addiction (Opioid and Alcohol) • Cardiovascular • CNS Disorders • Diabetes • Metabolic Disorders • Vascular Neurology
March 17, 2026
Synergistic disruption of the blood-brain barrier in tree shrews by Methamphetamine and HIV-1 Tat via TRPM2-Mediated astrocyte inflammation.
(PubMed, Brain Behav Immun)
- "This study revealed that METH and Tat could synergistically activate astrocytic TRPM2 channels to induce astrocyte-derived inflammatory response, and ultimately resulted in BBB injury. These findings highlight astrocyte-mediated inflammation as an important mechanism by which METH and Tat synergistically damage the BBB, and the TRPM2 channel represents a promising therapeutic target, providing novel insights into the mechanism of neurotoxicity caused by METH and HIV-1 Tat."
Journal • Human Immunodeficiency Virus • Infectious Disease • Inflammation • Psychiatry
1 to 25
Of
7882
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316